Syphilis Rapid Test Kits Market Size, Share & Industry Analysis, By Test Type (Treponemal, Non-Treponemal, Dual), By End-user (Diagnostic Centers, Research Laboratories, Hospitals, Clinics, Home Care Settings) Others and Regional Forecast, 2024-2032

Syphilis is a sexually transmitted disorder caused by the bacteria Treponema pallidum. Syphilis is majorly transmitted through sexual contact. As a result ulcers can occur in the vagina and around the external genitals. Transmission of syphilis can occur during anal, vaginal or oral sex. Moreover, pregnant women suffering from syphilis can transmit the infection to their unborn child. Increasing prevalence of the disorder in various regions of the world will significantly drive the syphilis rapid test kits market growth across the forecast timeframe. Syphilis rapid diagnostic test plays a crucial role in the early diagnosis of the disorder and thus preventing its irreversible consequences. Moreover, increasing technological advancements in the test kits for detection of syphilis is another major factor augmenting market growth.

The global syphilis rapid test kits market is anticipated to show considerable growth owing to a number of factors such as, increasing prevalence of sexually transmitted disorders across various economies and growing technological advancements in the diagnostic test kits. Point of care diagnostic tests for syphilis can be performed with minimal training and can also be done outside a laboratory setting. Hence, such tests can limit problems associated with lack of access to a laboratory or any other clinical settings. Additionally, growing prevalence of sexually transmitted disorders in the developing as well as developed economies will further propel industry expansion. For instance, as per the Centers for Disease Control and Prevention (CDC), nearly 20 million new sexually transmitted infections (STI) occur every year in the U.S., thus anticipated to boost syphilis rapid test kits market growth during forecast period.

The factors anticipated to hamper syphilis rapid test kits market growth are lack of precision in the test results coupled with dearth of awareness among the population of emerging economies about the adverse effects of syphilis. Moreover, China is facing an emerging epidemic of syphilis, owing to lack of knowledge pertaining to its treatment solutions. 

Key Players Covered:

Some of the major companies included in the global syphilis rapid test kits report are Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott (Alere), BD, Thermo Fisher Scientific Inc., Biokit S.A., Trinity Biotech, INTEC, NecLife, ELITech Group,  bioLytical Laboratories Inc. and few others. These players are implementing various inorganic strategies such as, novel product launch, acquisitions and mergers to gain a competitive edge over its peers.

As per the current market trend, the treponemal segment is expected to hold major market share during the projected duration owing to increasing prevalence of syphilis across the globe.

Key Insights

• Prevalence Data – For Key Countries


• New Product Launch


• Opportunity Assessment in Untapped Market


• Key Industry Developments - Mergers, Acquisitions, and Partnerships, 2018

Regional Analysis:

The global syphilis rapid test kits market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global syphilis rapid test kits market followed by Europe owing to a number of factors such as the increasing prevalence of sexually transmitted diseases, growing healthcare expenditure, rising awareness among the population about the adverse effects of syphilis, increasing adoption of rapid diagnostic tests in various clinical settings and technological advancements pertaining to several diagnostic test kits.

Furthermore, dearth of knowledge among the millennials about unprotected sexual intercourse is another major factor leading to such ever-growing epidemic. Hence, the aforementioned factors will significantly boost product demand, thus augmenting business growth. Moreover, favorable government campaigns and initiatives helping create awareness about the ill effects of STD’s will further drive industry growth.  

Segmentation

Syphilis Rapid Test Kits Industry Developments

• In June 2017, Bio-Rad Laboratories, Inc. announced the U.S. FDA approval of its BioPlex 2200 Syphilis Total syphilis test kit.


• In February 2015, bioLytical Laboratories Inc. announced that its INSTI HIV/Syphilis Multiplex Test has been cleared for immediate market entry in the European Union through its notified body.